Inmune BioINMB
13F holders, Q1 2024 (March 31)52holders
2famous investors
$11.75avg. 13F price*
At the end of Q1 2024, 52 institutions reported holding Inmune Bio Inc. (INMB) in their 13F filings. The largest holders were Vanguard Group Inc. ($6.4M), BlackRock Inc. ($2.8M) and MAI Capital Management ($2.1M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inmune Bio Inc.
- CUSIP
- 45782T105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $2.6M |
| Exits | 7 | $1.4M |
Ownership 52 holders
| Vanguard Group Inc. | 0.00% | No change | 541,329 | $6.4M |
| BlackRock Inc. | 0.00% | Reduce -6.9% | 240,166 | $2.8M |
| MAI Capital Management | 0.02% | Add +85.1% | 181,410 | $2.1M |
| Rhenman & Partners Asset Management AB | 0.20% | No change | 178,284 | $2.1M |
| Geode Capital Management, LLC | 0.00% | Add +0.5% | 170,802 | $2.0M |
| Millennium Management | 0.00% | Add +557.7% | 159,192 | $1.9M |
| Susquehanna International Group, LLP | 0.00% | Add +253.2% | 154,834 | $1.8M |
| Janney Montgomery Scott LLC | 0.00% | Reduce -13.8% | 140,911 | $1.7M |
| Deutsche Bank AG | 0.00% | No change | 109,848 | $1.3M |
| Goldman Sachs Group Inc. | 0.00% | New | 87,605 | $1.0M |
| Royal Bank of Canada | 0.00% | Add +43.2% | 82,736 | $973K |
| Jane Street Group, LLC | 0.00% | Add +71.5% | 73,970 | $869K |
| Citigroup Inc. | 0.00% | Add +33.8% | 48,044 | $565K |
| State Street Corp. | 0.00% | No change | 45,063 | $529K |
| Qube Research & Technologies Ltd | 0.00% | Add +50.0% | 44,165 | $519K |
| Man Group plc | 0.00% | Add +159.0% | 40,549 | $476K |
| UBS Group AG | 0.00% | Reduce -11.4% | 38,300 | $450K |
| Westside Investment Management, Inc. | 0.10% | Reduce -17.9% | 34,390 | $404K |
| Laird Norton Wetherby Trust Company, LLC | 0.05% | No change | 31,500 | $370K |
| Fermata Advisors, LLC | 0.08% | Add +6.9% | 31,451 | $370K |
| HRT Financial LP | 0.00% | New | 29,898 | $351K |
| Morgan Stanley | 0.00% | Add +114.6% | 27,479 | $323K |
| Marshall Wace, LLP | 0.00% | New | 26,825 | $315K |
| Bank of New York Mellon Corp | 0.00% | Reduce -21.9% | 26,089 | $307K |
| Northern Trust Corp. | 0.00% | Reduce -18.6% | 20,417 | $240K |
| Balyasny Asset Management L.P. | 0.00% | Reduce -13.8% | 20,047 | $236K |
| Brevan Howard Capital Management LP | 0.02% | New | 16,422 | $193K |
| Marathon Trading Investment Management LLC | 0.07% | New | 14,500 | $170K |
| Squarepoint Ops LLC | 0.00% | New | 13,441 | $158K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.04% | New | 13,438 | $158K |
| Osaic Holdings, Inc. | 0.00% | Add +14.7% | 12,270 | $144K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 11,059 | $130K |
| Laurion Capital Management LP | 0.00% | No change | 11,011 | $129K |
| Financial Advocates Investment Management | 0.01% | Reduce -16.0% | 10,500 | $123K |
| NewEdge Advisors, LLC | 0.00% | Add +0.5% | 10,475 | $123K |
| Beacon Pointe Advisors, LLC | 0.00% | No change | 10,368 | $122K |
| LPL Financial LLC | 0.00% | Reduce -0.7% | 10,022 | $118K |
| Bank of America Corp. | 0.00% | Reduce -37.9% | 8,768 | $103K |
| Cubist Systematic Strategies, LLC | 0.00% | New | 4,782 | $56K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +47.0% | 2,255 | $26K |
| Leonteq Securities AG | 0.00% | No change | 1,600 | $19K |
| Valley National Advisers Inc. | 0.00% | No change | 1,000 | $11K |
| Continuum Advisory, LLC | 0.00% | New | 1,000 | $11K |
| FMR LLC | 0.00% | Add +588.2% | 585 | $7K |
| Clearstead Advisors, LLC | 0.00% | Add +16.7% | 490 | $5K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $5K |
| Lanark Financial, Inc. | 0.00% | No change | 270 | $3K |
| IFP Advisors, Inc | 0.00% | No change | 184 | $2K |
| Wells Fargo & Company | 0.00% | Add +1.4% | 147 | $2K |
| FNY Investment Advisers, LLC | 0.00% | No change | 100 | $1K |
| Citadel Advisors | 0.00% | Reduce -99.9% | 30 | $353 |
| Macquarie Group Ltd. | 0.00% | New | 444 | $5 |
"% of holder's portfolio" is INMB's weight in each manager's 13F, not the share of Inmune Bio Inc. the manager owns.